| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_866dd4afd2818ad5c6a910b19efa7f10 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-324
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-30 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-899
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-105 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-899 |
| filingDate |
2015-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0bc55eda3e48229015eb1b04c04f8701
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_720c6bc287befbcae7eb38d5f824881e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5aa5589788755274246c699bae993e84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e78c82325d583e1a5c9ab1e0160240d |
| publicationDate |
2017-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20170010249-A |
| titleOfInvention |
Composition for Inhibiting Angiogenesis Using an Extract of Zizania Latifolia |
| abstract |
To transition the present invention is to vascular endothelial cells (Human Umbilical Vein Endothelial Cells) growth inhibition also the addition of the adhesion and suppresses the movement and increases the expression of p27 in inhibitor of cell cycle in the cell cycle G 1 phase S phase of the And inhibiting the expression of cyclin E and cdk2 that are involved in the regulation of angiogenesis. |
| priorityDate |
2015-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |